FAKTOR-ZERTIFIKAT - BIOGEN IDEC | Market Closed - Bid/Ask 13:40:33 2024-06-07 EDT | After market 14:13:43 | |||
| 5.54 EUR | -19.36% |
|
5.3 | -4.33% |
| Current month | +26.99% | ||
| 1 month | +7.85% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-07 | 5.54 | -19.36% |
| 24-06-06 | 6.87 | -13.69% |
| 24-06-05 | 7.96 | +11.33% |
| 24-06-04 | 7.15 | +15.70% |
| 24-06-03 | 6.18 | +14.23% |
Delayed Quote Börse Stuttgart
Last update June 07, 2024 at 01:40 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | J.P. Morgan |
| WKN | JK4CZ8 |
| ISIN | DE000JK4CZ81 |
| Date issued | 2024-03-22 |
| Strike | 203.1 $ |
| Maturity | Unlimited |
| Parity | 4.32 : 1 |
| Emission price | 10.17 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.04 € |
|---|---|
| Lowest since issue | 2.34 € |
| Spread | 0.02 € |
| Spread % | 0.38% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
232
USD
Average target price
284.6
USD
Spread / Average Target
+22.70%
- Stock Market
- Certificates
- Certificat
